 benefici effect alpha activ myocardi stun dog studi adrenoceptor activ benefici dysfunct reperfus brief period ischemia stun myocardium open-chest dog contractil dysfunct fraction shorten FS hour onset reperfus minut complet occlus left anterior coronari arteri pretreat prazosin micrograms/kg/min i.c contractil dysfunct untreat condit versu prazosin treatment alpha agonist methoxamin microgram/kg/min i.c norepinephrin microgram/kg/min i.c rauwolscin propranolol contractil dysfunct FS methoxamine-tr group untreat group FS norepinephrine-tr group versu propranolol group adenosin releas hyperem coronari flow respons earli reperfus period prazosin-tr group alpha stimul group result benefici effect alpha activ due enhanc releas adenosin cause-effect relat extent adenosin releas contractil dysfunct reperfus adenosin receptor methoxamine-tr group treatment FS benefici effect enhanc adenosin releas alpha stimul furthermor prazosin-tr group adenosin micrograms/kg/min left anterior coronari arteri minut hour onset reperfus hyperem coronari flow contractil dysfunct FS level alpha stimul group treatment papaverin deleteri effect prazosin fact compar hyperem flow lactat product minut onset reperfus contractil function prazosin-tr methoxamine-tr group untreat group electron microscop examin irrevers myocardi injuri pharmacolog intervent alpha activ magnitud myocardi stun cellular mechan due enhanc adenosin releas alpha activ abstract truncat AT word